12 Jun 2019

WBD has advised international client Mpac Group Plc (Mpac) on its acquisition of the entire issued share capital of Lambert Automation Limited (Lambert) for an initial consideration of £15.0 million. 

Lambert was founded in 1973 and is one of the UK's leading providers of technology leading automation solutions to the medical and consumer healthcare markets. The acquisition represents a compelling fit with Mpac’s strategic intent of being a market leader in the provision of full-line automation and packaging solutions for the pharmaceutical, healthcare and food and beverage sectors. Mpac will enter the medical and healthcare product assembly and packaging market fulfilling the expected increase in demand for wellness products.

The Corporate team at WBD was led by Partner Robert Phillips; who was assisted by Managing Associate Stacey Hall and Solicitor David Ridley.

WBD's relationship with Mpac is longstanding, having advised them (under their previous name Molins PLC) on the sale of their Instrumentation & Tobacco Machinery business in 2017, which Robert and Stacey also led on.

Robert Phillips, Partner in the Corporate team at Womble Bond Dickinson commented:

"After working with Mpac on its strategic disposal in 2017 it was always intended that the Group would look for appropriate acquisitions.  It has been great to work with Tony, Duncan and the team again on this project" 

Duncan Tyler, Mpac Group's Corporate Development Director & Company Secretary, said:

"We have developed a good relationship with the WBD team from their involvement in the disposal of our Instrumentation & Tobacco Machinery business in 2017.  For this transaction WBD provided excellent support and advice and remained focused on helping us meet our completion timeline"

Ranking in the UK's top 20 law firms, WBD provides legal expertise in eleven key sectors from across eight offices in the UK, including London and 19 offices in the US. The firm has a large corporate practice in the UK advising national and international clients on a broad range of corporate transactions, particularly M&As, IPOs, private equity investments, growth and development capital, and public company fundraisings.